.2 months. The estimated pooled success rate
at 3 years was highest after EVLA (94%), followed by RFA
(84%), HL/S (78%), and foam sclerotherapy (77%). EVLA

was significantly superior to other treatment modalities in
abolition of the saphenous reflux. Foam therapy and RFA
were equally effective as surgery. The meta-analysis concluded that endovenous thermal ablations or foam sclerotherapy is at